Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats
References (28)
- et al.
Drug disposition in spontaneously hypertensive rats
Pharmacol. Res. Commun.
(1980) - et al.
Differential sensitivity of spontaneously hypertensive rats to the hypothermic effect of dopaminergic drugs
Life Sci.
(1980) - et al.
Experimental methods in cancer therapeutics
J. Pharm. Sci.
(1982) - et al.
Adriamycin-induced nephrotic syndrome in rats
Lab. Invest.
(1982) - et al.
Adriamycin: A new anticancer drug with significant clinical activity
Ann. Intern. Med.
(1974) - et al.
Doxorubicin hydrochloride-associated renal failure
Arch. Intern. Med.
(1977) - et al.
Adriamycin given as a weekly schedule without a loading course: Clinically effective with reduced incidence of cardiotoxicity
Cancer Treat. Rep.
(1980) - et al.
Adriamycin (NSC123127) cardiotoxicity: A clinicopathologic correlation
Cancer Chemother. Rep.
(1975) - et al.
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine
J. Clin. Invest.
(1981) - et al.
Hypertensive diabetic cardiomyopathy in the rat: Ultrastructural features
Virchows Arch. Pathol. Anat.
(1983)
Pretreatment with ICRF-187 markedly reduces chronic doxorubicin cardiotoxicity in beagle dogs
Cancer Res.
(1981)
Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine
Lab. Invest.
(1983)
Inhibition of cardiotoxic, nephrotoxic and neurotoxic effects of doxorubicin by ICRF-159
Pharmacology
(1983)
Clinicopathologic analysis of Adriamycin cardiotoxicity
Cancer
(1973)
Cited by (0)
Copyright © 1985 Published by Elsevier Inc.